US Stock MarketDetailed Quotes

AVTE Aerovate

Watchlist
  • 2.430
  • +0.010+0.41%
Close Feb 28 16:00 ET
  • 2.430
  • 0.0000.00%
Post 16:16 ET
70.43MMarket Cap-0.81P/E (TTM)

About Aerovate Company

Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.

Company Profile

SymbolAVTE
Company NameAerovate
Listing DateJun 30, 2021
Issue Price14.00
Founded2018
CEOMr. Timothy P. Noyes
MarketNASDAQ
Employees51
Fiscal Year Ends12-31
Address930 Winter Street,Suite M-500
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-617-443-2400
Websitehttp://www.aerovatetx.com

Company Executives

  • Name
  • Position
  • Salary
  • Timothy P. Noyes
  • Director and Chief Executive Officer
  • 3.07M
  • Dr. Marinus Verwijs, PhD
  • Chief Technical Officer
  • --
  • George A. Eldridge
  • Chief Financial Officer, Treasurer and Principal Accounting Officer
  • 2.13M
  • Dr. Benjamin T. Dake, PhD
  • President, Chief Operating Officer and Secretary
  • --
  • Dr. Hunter Gillies, M.B.
  • Chief Medical Officer
  • --
  • Timothy J. Pigot
  • Chief Commercial Officer
  • 2.45M
  • Ralph Niven,PhD
  • Chief Scientific Officer
  • --
  • Mark T. Iwicki
  • Chairman of the Board
  • 218.30K
  • Donald J. Santel
  • Independent Director
  • 568.54K
  • Dr. David S. Grayzel, M.D.
  • Independent Director
  • 225.99K
  • Dr. Joshua Resnick, M.B.A.,M.D.
  • Independent Director
  • 174.80K
  • Allison Dorval
  • Independent Director
  • 185.80K
  • Habib Joseph Dable
  • Independent Director
  • 363.25K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LINTEX
920106
+30.00%
LINGOOD
833284
+29.98%
NTGEC
870436
+29.98%
4
CG MED EQUIP.
838810
+29.97%
5
Jiayu Holding
300117
+20.48%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025